United Kingdom (UK) Genetic Disease Diagnostic Market (2025-2031) | Competitive Landscape, Share, Analysis, Growth, Segmentation, Companies, Outlook, Size & Revenue, Trends, Value, Forecast, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Genetic Disease Diagnostic Market - Industry Life Cycle

3.4 United Kingdom (UK) Genetic Disease Diagnostic Market - Porter's Five Forces

3.5 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic diseases in the UK population

4.2.2 Technological advancements in genetic testing and diagnostics

4.2.3 Growing awareness and acceptance of genetic testing for early disease detection

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for genetic testing

4.3.2 High costs associated with genetic disease diagnostics

4.3.3 Limited accessibility to genetic testing services in certain regions of the UK

6.1 United Kingdom (UK) Genetic Disease Diagnostic Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Prenatal Diagnosis, 2021- 2031F

6.1.4 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2 United Kingdom (UK) Genetic Disease Diagnostic Market, By Application

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Inherited Disorder Testing, 2021- 2031F

6.2.3 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Pharmacogenetic Testing (Pgx), 2021- 2031F

6.2.4 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Human Leukocyte Antigen (Hla) Testing, 2021- 2031F

6.2.5 United Kingdom (UK) Genetic Disease Diagnostic Market Revenues & Volume, By Oncology Testing, 2021- 2031F

7.1 United Kingdom (UK) Genetic Disease Diagnostic Market Export to Major Countries

7.2 United Kingdom (UK) Genetic Disease Diagnostic Market Imports from Major Countries

8.1 Adoption rate of genetic testing services by healthcare providers

8.2 Number of genetic testing labs and facilities in the UK

8.3 Percentage of the UK population with access to genetic disease diagnostic services

9.1 United Kingdom (UK) Genetic Disease Diagnostic Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 United Kingdom (UK) Genetic Disease Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United Kingdom (UK) Genetic Disease Diagnostic Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Genetic Disease Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters